These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3324305)

  • 1. The pathogenesis and consequence of non steroidal anti-inflammatory drug induced small intestinal inflammation in man.
    Bjarnason I; Zanelli G; Smith T; Smethurst P; Price AB; Gumpel MJ; Levi AJ
    Scand J Rheumatol Suppl; 1987; 64():55-62. PubMed ID: 3324305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of non-steroidal anti-inflammatory drugs on the human small intestine.
    Bjarnason I; Zanelli G; Prouse P; Williams P; Gumpel MJ; Levi AJ
    Drugs; 1986; 32 Suppl 1():35-41. PubMed ID: 3780475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental evidence of the benefit of misoprostol beyond the stomach in humans.
    Bjarnason I
    J Rheumatol Suppl; 1990 Feb; 20():38-41. PubMed ID: 2109075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The changing gastrointestinal side effect profile of non-steroidal anti-inflammatory drugs. A new approach for the prevention of a new problem.
    Bjarnason I; Macpherson A
    Scand J Gastroenterol Suppl; 1989; 163():56-64. PubMed ID: 2683029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal permeability in the pathogenesis of NSAID-induced enteropathy.
    Bjarnason I; Takeuchi K
    J Gastroenterol; 2009; 44 Suppl 19():23-9. PubMed ID: 19148789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID-enteropathy in the rat.
    Somasundaram S; Sigthorsson G; Simpson RJ; Watts J; Jacob M; Tavares IA; Rafi S; Roseth A; Foster R; Price AB; Wrigglesworth JM; Bjarnason I
    Aliment Pharmacol Ther; 2000 May; 14(5):639-50. PubMed ID: 10792129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of commonly used NSAID's on gastric mucosa. A clinico-endoscopic and histopathological study.
    Misra R; Pandey H; Chandra M; Chandra M; Agarwal PK; Pandeya SN
    J Assoc Physicians India; 1990 Dec; 38(12):913-5. PubMed ID: 2096127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal permeability and inflammation in patients on NSAIDs.
    Sigthorsson G; Tibble J; Hayllar J; Menzies I; Macpherson A; Moots R; Scott D; Gumpel MJ; Bjarnason I
    Gut; 1998 Oct; 43(4):506-11. PubMed ID: 9824578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Meloxicam].
    Sternon J; Appelboom T
    Rev Med Brux; 1998 Feb; 19(1):29-32. PubMed ID: 9553452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Digestive lesions related to N.S.A.I.D. (epidemiology and prevention)].
    Florent C
    Acta Gastroenterol Belg; 1992; 55(5-6):423-9. PubMed ID: 1288040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible Interaction of Nonsteroidal Anti-inflammatory Drugs Against NF-κB- and COX-2-Mediated Inflammation: In Silico Probe.
    Vardhini SP; Sadiya H; Beigh S; Pandurangan AK; Srinivasan H; Anwer MK; Waseem M
    Appl Biochem Biotechnol; 2022 Jan; 194(1):54-70. PubMed ID: 34843076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs.
    Bjarnason I; Williams P; So A; Zanelli GD; Levi AJ; Gumpel JM; Peters TJ; Ansell B
    Lancet; 1984 Nov; 2(8413):1171-4. PubMed ID: 6150232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumour necrosis factor agents reduce non-steroidal anti-inflammatory drug-induced small bowel injury in rheumatoid arthritis patients.
    Watanabe T; Tanigawa T; Shiba M; Nadatani Y; Nagami Y; Sugimori S; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Koike T; Arakawa T
    Gut; 2014 Mar; 63(3):409-14. PubMed ID: 23697473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsteroidal antiinflammatory drugs and the small intestine.
    Fortun PJ; Hawkey CJ
    Curr Opin Gastroenterol; 2005 Mar; 21(2):169-75. PubMed ID: 15711208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Repercussions and undesirable effects of non-steroidal anti-inflammatory agents on the intestine. 1: Experimental data and pathophysiological effects].
    Gargot D; Chaussade S
    Gastroenterol Clin Biol; 1993; 17(6-7):485-91. PubMed ID: 8243935
    [No Abstract]   [Full Text] [Related]  

  • 16. Non-steroidal anti-inflammatory drug induced injury to the small intestine.
    Tachecí I; Kopácová M; Rejchrt S; Bures J
    Acta Medica (Hradec Kralove); 2010; 53(1):3-11. PubMed ID: 20608226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine.
    Bjarnason I; Williams P; Smethurst P; Peters TJ; Levi AJ
    Gut; 1986 Nov; 27(11):1292-7. PubMed ID: 3466837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small-bowel side-effects of non-steroidal anti-inflammatory drugs.
    Aabakken L
    Eur J Gastroenterol Hepatol; 1999 Apr; 11(4):383-8. PubMed ID: 10321753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small intestinal injury in NSAID users suffering from rheumatoid arthritis or osteoarthritis.
    Tachecí I; Bradna P; Douda T; Baštecká D; Kopáčová M; Rejchrt S; Lutonský M; Soukup T; Bureš J
    Rheumatol Int; 2016 Nov; 36(11):1557-1561. PubMed ID: 27549792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased intestinal permeability in patients with rheumatoid arthritis: a side-effect of oral nonsteroidal anti-inflammatory drug therapy?
    Jenkins RT; Rooney PJ; Jones DB; Bienenstock J; Goodacre RL
    Br J Rheumatol; 1987 Apr; 26(2):103-7. PubMed ID: 3103807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.